tiprankstipranks

Daniel Virnich Insider Profile

11 Followers
Daniel Virnich, CEO at Oncology Institute, Inc., holds 916.95K shares in Oncology Institute, Inc. (Ticker: TOI).
tipranks
Daniel Virnich

Daniel Virnich
Oncology Institute, Inc. (TOI)
CEO

Not Ranked
Daniel Virnich has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$452K
100.00%
A breakdown of Daniel Virnich's holdings

Insider Roles

Oncology Institute, Inc.
(TOI)
CEO
Roles that Daniel Virnich holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Daniel Virnich

Daniel Virnich's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncology Institute, Inc.
May 23, 2024
CEO
Uninformative Buy
$452.05K
Daniel Virnich has not reported any informative transactions for TOI, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 16, 2021
Uninformative Buy
$0.00
-
$0.00
Mar 23, 2022
Uninformative Buy
$0.00
-
$0.00
Nov 21, 2022
Uninformative Buy
$0.00
-
$0.00
May 23, 2024
Uninformative Buy
$0.00
-
$0.00
Dec 08, 2022
Uninformative Buy
$301.00K
-
$0.86
List of latest transactions for each holding click on a transaction to see Daniel Virnich's performance on stock

Daniel Virnich insider profile FAQ

What is the percentage of profitable transactions made by Daniel Virnich?
The percentage of profitable transactions made by Daniel Virnich is ―.
    What is the average return per transaction made by Daniel Virnich?
    The average return per transaction made by Daniel Virnich is ―.
      What stocks does Daniel Virnich hold?
      Daniel Virnich holds: TOI stocks.
        What was Daniel Virnich’s latest transaction?
        Daniel Virnich latest transaction was an Uninformative Buy of ―.
          What was Daniel Virnich's most profitable transaction?
          Daniel Virnich’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Daniel Virnich's role in Oncology Institute, Inc.?
            Daniel Virnich's role in Oncology Institute, Inc. is CEO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.